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Abstract
Aneurysms of the vascular wall represent a final common pathway for a number of inflammatory 
processes including atherosclerosis and idiopathic vasculitis syndromes. Kawasaki disease is an 
acute, self-limited vasculitis in children and the leading cause of acquired coronary artery 
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aneurysms. We sought to identify shared molecular mechanisms of aneurysm formation by 
genotyping 8 polymorphisms in MMP-1, 3, 7, 12 and 13 in the gene cluster on Chr.11q22 whose 
gene products have been implicated in aneurysm formation or are known to have elastase activity. 
We genotyped 482 US-UK Kawasaki disease patients (aneurysm+: n=111, aneurysm−: n=371) 
and tested our findings in an independent cohort of 200 Japanese Kawasaki disease patients 
(aneurysm+: n=58, aneurysm−: n=142). Analysis of the five MMP genes identified modest trends 
in allele and genotype frequencies for MMP-3 rs3025058 (−/T) and haplotypes containing MMP-3 
rs3025058 (−/T) and MMP-12 rs2276109 (A/G) (nominal p= 2-4 × 10−5) that conferred increased 
risk of aneurysm formation in US-UK subjects. This finding was validated in Japanese subjects 
and suggests the importance of this locus in aneurysm formation in children with Kawasaki 
disease. The region encompassing these risk haplotypes is a prime candidate for re-sequencing to 
look for rare genetic variation that may influence aneurysm formation.
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Introduction
Aneurysms of the vascular wall complicate many different diseases that involve vessel wall 
inflammation and destruction of extracellular matrix (ECM) and elastic fibers. In children 
with Kawasaki disease (KD), coronary artery aneurysms (CAA) form in 25% of untreated 
patients and 5% of patients treated with intravenous immunoglobulin (IVIG) within the first 
10 days after fever onset. A hallmark of CAA is focal destruction of the internal elastic 
lamina with early neutrophil infiltration followed by macrophages and cytotoxic T-
lymphocytes 1. For this reason, enzymes that cleave elastin have been implicated in the 
pathogenesis of KD 2, 3. Proteases capable of degrading elastin include neutrophil elastase 
and the matrix metalloproteinases (MMP)-2, 3, 7, 9 and 12 4. MMPs are zinc-dependent 
endopeptidases produced by a wide variety of cell types. In addition to the degradation of 
(ECM), MMPs also cleave cytokines and chemokines 5 and influence recruitment of 
inflammatory cells. Therefore MMPs play important roles in both inflammation and tissue 
remodeling.
According to a current paradigm, KD is triggered by an infectious agent that elicits an 
inflammatory response directed at cardiovascular tissues in genetically susceptible hosts6. A 
genetic influence on disease susceptibility in KD has been explored in candidate gene 
association studies, a genome-wide linkage analysis of siblings concordant for KD followed 
by linkage disequilibrium mapping, and a genome-wide association study 7-11. However, 
fewer studies have explored the impact of genetic variation on aneurysm formation because 
of the difficulty in collecting a sufficient sample size of patients with this phenotype for 
genotyping. To bridge this gap in knowledge, we collaborated with groups in the UK and 
Japan to collect DNA from KD patients and determined the contribution of 5 MMP genes 
(MMP-1, 3, 7, 12 and 13) to CAA formation as these MMPs have been implicated in 
atherosclerotic coronary artery and abdominal aneurysms or are known to have elastase 
activity 4, 12, 13. We genotyped 8 single nucleotide polymorphisms (SNPs) in these 5 MMP 
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genes clustered on Chromosome 11 and analyzed haplotypes in the US-UK cohort. These 
results were tested in an independent cohort of Japanese KD subjects to examine the 
association of this region with CAA across different ethnic populations.
Methods
Subjects
Details of the US-UK subjects and their clinical presentation and case definition have been 
previously described 9. Briefly, KD patients (n=482) were recruited at Rady Children's 
Hospital San Diego, CA, Boston Children's Hospital, Boston, MA, and Imperial College 
School of Medicine, London, UK. KD patients from Japan (n=200) were recruited by 
investigators at Yamaguchi University and Oita Children's Hospital Japan. Parental consent 
and subject assent when appropriate were obtained for all subjects. The Institutional Review 
Boards of the participating centers reviewed and approved this study.
Demographic and clinical data were collected on all subjects as previously described 9 
(Table 1). The distribution of different ethnic groups was similar between the CAA+ and 
CAA− cohorts. For the US subjects, coronary artery status was assessed by 
echocardiography during the acute, subacute, and convalescent phase of the illness. 
Measurements of the internal diameters of the proximal right (R) and left anterior 
descending (LAD) coronary arteries (CA) were normalized for body surface area and 
expressed as standard deviation units from the mean (Z scores). For US subjects, CAA was 
defined as a Z-score ≥4.0 in the first year after KD onset in association with an internal 
diameter ≥ 1.5 times the adjacent segment 14. For the UK and Japanese subjects, Z scores 
were not available and coronary artery lesions (aneurysm or ectasia) were defined according 
to the Japanese Ministry of Health criteria (internal lumen diameter ≥3 mm for children < 5 
yrs and ≥4 mm for children ≥ 5 yrs or the internal diameter of one or more segments ≥1.5 
times the diameter of the adjacent segment15.
Genotyping
Genomic DNA from whole blood or mouth wash samples was extracted as previously 
described 9. We chose 8 SNPs from 5 MMP genes (Figure 1) that had positive disease 
associations in the published literature 16-23 (Figure 2). Genotyping was performed using a 
multiplex PCR-based, sequence-specific oligonucleotide hybridization research assay 
(Roche Molecular Systems, Pleasanton, CA) as previously described 9. To genotype 
MMP13 rs2252070 (A/G) we used a TaqMan allele discrimination assay (Applied 
Biosystem, Assay ID: C__25474083_10) according to the manufacturer's instructions. 
Different numbers of subjects were genotyped for different loci because of limited 
availability of some of the genotyping reagents that were discontinued by the manufacturer 
before the study was completed (Supplemental Table 1 and 2). Data quality control was 
performed as previously described 9. SNPs with allele frequencies less than 1%, genotype 
call rate less than 93%, or deviation from HWE were excluded from further analysis.
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Statistical analyses
Case-control association studies between MMP SNPs and CA status were analyzed via the 
general linear model: Yi = α + β Xi + ∈i. The genetic models that were considered were the 
codominant model (genotype) and the additive model (allele). Under the codominant model, 
a particular SNP is considered a categorical variable with one level for each genotype for a 
total of three levels. To assess the association between phenotype Y and each SNP, the 
above general linear model is used, where α represents the intercept, Xi is the ith subject's 
genotype score for a given marker, and ∈i is normally distributed with mean 0 and variance 
σ2. Under the dominant model, Xi=1 if the ith subject has at least one minor allele or Xi=0 
otherwise. Under the additive model, Xi indicates the ith subject's number of minor alleles. 
This is equivalent to the test based on the allele frequency. Multiple testing corrections were 
not applied and nominal p values are shown in the tables. Analysis was performed using the 
R software (version 2.6.2, http://www.r-project.org/) and the R package SNPassoc.
Haplotype associations between MMP SNPs and CA status were analyzed using a moving 
window approach. The EM algorithm 24 was used to estimate haplotype frequencies and to 
account for missing genotypes. Score statistics were computed to test associations between 
the haplotypes and various traits. Analyses were performed using the R package haplo.stats 
25. Correction for multiple testing was performed for single locus and haplotype analyses 
according to the following calculation: single locus: 0.05/number of SNPs tested; 
haplotypes: 0.05/number of observed haplotypes/number of haplotypes with nominal 
p<0.05.
Results
Single-locus analysis in the US-UK cohort
Case-control analysis of the multiethnic US-UK cohort (111 KD subjects with aneurysms 
vs. 371 KD subjects with normal or transiently dilated coronary arteries) was performed and 
genotype data met quality control criteria on 8 SNPs in 5 MMP genes. Modest trends in 
allele and genotype frequencies were noted between the two groups for MMP-3 rs3025058 
(−/T) (allele nominal p=0.031, OR=0.72, 95%CI 0.54-0.97; genotype nominal p=0.015) 
suggesting that the T allele in the MMP-3 promoter contributes to protection against 
aneurysm formation. Another SNP in MMP-3, rs679620 (A/G) was associated with a trend 
towards protection (allele nominal p=0.089, OR=0.76, 95% CI 0.56-1.05; genotype nominal 
p=0.042) (Supplemental Table 1). None of these associations remained significant after 
correction for multiple testing. To explore the possible effect of population stratification on 
our analysis, we performed single-locus analyses using only self-reported Caucasian 
subjects (CAA+ n= 75, CAA− n= 215). No significant differences between the CAA+ and 
CAA− groups were detected with this smaller sample (data not shown).
Haplotype analysis in US-UK subjects
We analyzed SNPs in the 5 MMP genes located in a cluster on chromosome 11q22 (MMP-1, 
3, 7, 12 and 13) (Figure 1). Several haplotypes were associated with CAA formation in the 
US-UK subjects (Table 2). Analysis using a window of two SNPs identified 2 haplotypes 
both with the del allele (− allele) of MMP-3 rs3025058 (−/T) that were associated with 
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increased risk of aneurysm formation (nominal p=0.03 and 0.04 respectively). The 
association of the del allele of MMP-3 rs3025058 (−/T) with the A allele of rs679620 (A/G) 
and the A allele of rs2276109 (A/G) in MMP-12 remained constant, suggesting strong 
linkage disequilibrium in this region (D′ between MMP-3 rs3025058 (−/T) and rs679620 
(A/G): 0.92, MMP-3 rs3025058 (−/T) and MMP-12 rs2276109 (A/G): 0.85). Haplotypes 
containing 3 to 8 SNPs that were associated with CAA all included the del allele of MMP-3 
rs3025058 (−/T). Haplotypes containing the T allele were not significantly associated. Two 
haplotypes were significant after correction for multiple sample testing (Table 2, nominal p= 
2-4 × 10−5). The risk haplotypes consistently included the G allele of MMP-13 rs2252070 
(A/G), the A and C alleles of MMP7 rs11568818 (A/G), and rs11568819 (C/T), respectively. 
To explore the possible effects of population stratification on our analysis, we performed 
haplotype analyses using only self-reported Caucasian subjects from the larger, multiethnic 
cohort (CAA+ n= 75, CAA− n= 215) (Table 3). Two haplotypes identified in the multiethnic 
cohort were again showed association with CAA (nominal p=0.0034 and p=0.0039) in the 
all-Caucasian subset. Four 5-7 SNP haplotypes were associated with protection against 
aneurysm formation while these same haplotypes with the opposite alleles at MMP-1 
rs1799750 (−/G), MMP-3 rs679620 (A/G) and rs3025058 (−/T) were associated with 
aneurysm formation in the larger, multiethnic cohort.
Single-locus analysis in Japanese cohort
To test the influence of genetic variation in MMP-3 and MMP-12 in a different ethnic 
cohort, single-locus analysis for CAA in the Japanese cohort was performed for SNPs in 
MMP-3 and MMP-12. MMP-12 rs2276109 (A/G) was associated with CAA formation with 
the G allele conferring increased risk (p=0.006, OR=4.92, 95%CI 1.54-15.73) 
(Supplemental Table 2).
Haplotype analysis in Japanese subjects
We analyzed the haplotypes of MMP-3 and MMP-12 in a Japanese cohort and found that 
haplotypes containing the MMP-12 rs2276109 (A/G) G allele and MMP-3 rs3025058 (−/T) 
T allele were associated with CAA after correction for multiple testing (nominal 
p=0.003-0.0009); however, these haplotypes were rare in the study cohort (frequencies: 
CAA−: 0.01,CAA+: 0.10)(Table 4).
Discussion
We tested the hypothesis that genetic variation in MMP genes influences coronary artery 
damage in patients with KD. Haplotypes in MMP-3 and MMP-12, both with elastolytic 
activity, were associated with aneurysm formation in our mixed ethnic cohort from the US-
UK and an all-Caucasian subset of the cohort. Analysis of an independent cohort of 
Japanese KD subjects validated the influence of haplotypes in MMP-3 and MMP-12 on 
aneurysm formation, although different alleles were associated with increased risk in the 
Japanese cohort. This may be due to a difference in haplotype structure with the 
consequence that the functional genetic variant is linked differently to these alleles in the 
two populations. Fine mapping or re-sequencing of this region in these two populations may 
uncover the specific genetic variation associated with CAA formation.
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We found a relationship between haplotypes including SNPs in MMP-12, and aneurysm 
formation in KD. MMP-12, which encodes for a macrophage elastase, has multiple 
functions that could be important in aneurysm pathogenesis. In addition to degrading ECM 
proteins, MMP-12 may promote macrophage recruitment to the vessel wall by activating 
TNF-α or by modulating levels of proinflammatory cytokines such as monocyte chemotactic 
protein-1 (MCP-1) 26. The A allele of MMP-12 rs2276109 (A/G) shows a higher affinity for 
the transcription factor activator protein-1 (AP-1) and higher expression levels in reporter 
gene assays 17. MMP-12 rs652438 (A/G) in exon 8 changes the neutral amino acid, 
asparagine, to the neutral amino acid, serine, in the hemopexin domain, which is thought to 
bind to TIMP-1. Functional studies have not been performed to determine the consequence 
of this amino acid substitution.
The haplotypes associated with aneurysm formation also included MMP3. MMP-3 also has 
elastolytic capabilities and plays an important role in other diseases involving vascular wall 
inflammation including AAA, atherosclerosis, and Takaysu's arteritis 27. MMP-3 rs3025058 
(−/T) is a well-established functional variant. The T allele in this promoter region 
preferentially binds to the transcriptional repressor, NFκB p50 homodimer, and is associated 
with reduced transcript abundance 19. MMP-3 rs679620 (A/G), is located close to a 
cleavage site and the substitution of positively charged lysine for negatively charged 
glutamic acid may alter protein function. In our US-UK subjects, haplotype analysis 
identified the del-A as the risk haplotype. Our findings are in agreement with a study of 
MMP-3 rs3025058 (−/T) in a small Korean cohort of KD subjects (CAA+; n=34, CAA−; 
n=49) 28. Homozygotes for the MMP-3 T allele had increased risk of CAA. Although this 
locus was associated with CAA in both the Japanese and US-UK, different alleles were 
implicated suggesting a difference in LD structure in this region. As for MMP-12, this 
region should be considered for re-sequencing efforts to further understand the role of 
genetic variation on CAA.
Recently, the A allele of MMP-13 rs2252070 (A/G) was reported to be associated with CAA 
formation in Japanese cohorts (CAA+; n=44, CAA−; n=92)29. MMP-13 rs2252070 (A/G) 
was only genotyped in the US-UK cohort in our study and not significantly associated in the 
single locus analysis (CAA+; n=62, CAA−; n=202). The risk haplotype for CAA formation 
included the G allele of MMP-13 rs2252070 (A/G) in our US-UK cohort, which differs from 
the published results in Japanese. Variation in population structure or our larger sample size 
may account for these differences. The effect of genetic variation in MMP-13 on CAA 
formation in Japanese subjects should be explored in future studies.
Discrepant results were obtained for the effect of MMP-1 rs1799750 on CAA in different 
cohorts. In the multiethnic US-UK cohort, both alleles of MMP-1 rs1799750 (−/G) were in 
haplotypes associated with CAA (Table 2). However, in the Caucasian only analysis (Table 
3), the deletion allele MMP-1 rs1799750 (−/G) was associated with protection against CAA, 
while the G allele was associated with increased risk. One possible interpretation is that the 
LD structure in Caucasians is different, thus driving the difference in results.
We recognize several limitations to our study. First, we performed case-control analyses 
using a multiethnic US-UK cohort to increase the statistical power. We justified this based 
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on similar allele frequencies in HapMap for the MMP SNPs in Caucasian-Hispanics and 
Caucasians, which comprised 85% of our cohort. Analyses performed on an all-Caucasian 
subset with reduced sample size supported the results from the analysis of the multiethnic 
cohort. Although this one of the largest studies on genetic determinants influencing CAA 
formation, the number of subjects with CAA was still limited and results will need to be 
validated in additional, independent cohorts. Our study did not replicate the association of 
SNPs in MMP1329, but a smaller cohort was genotyped for this region in our study, thus 
reducing our power to detect an association. This should be addressed in future studies with 
a larger sample size. As another limitation, our genotyping approach did not include all 
haplotype tagging SNPs across the MMP gene cluster and not all genes/SNPs were 
genotyped in both cohorts. Detailed fine mapping or re-sequencing of MMP-3 and MMP-12 
should be considered in future studies. Finally, the coronary artery phenotyping varied 
slightly between the western countries and Japan. Some subjects in the Japanese aneurysm 
group might have been classified as transiently dilated according to the US criteria and 
therefore included with the normal group. However, the number of subjects who might have 
been differently assigned in the US and Japanese cohorts would have been small.
In summary, haplotype analyses suggested an influence of genetic variation in genes for the 
elastolytic MMPs in the gene cluster on Chr.11 on formation of CAA in KD patients, which 
was validated in an independent cohort. In this case, it is better to describe false discovery 
rate of the results. MMP-3 and MMP-12 haplotypes have been associated with susceptibility 
to aneurysms in other conditions, which suggests a shared molecular mechanism that unifies 
these inflammation-associated aneurysm syndromes.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. MMP Gene cluster on 11q22
Arrowheads show the direction of genes. Arrows on right indicate intergenic distance in the 
424Kb region. Genes in bold were genotyped in this study.
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Figure 2. 8 SNPs from 5 MMP genes genotyped in KD patients
Gene structure and the location of SNPs are color-coded: red boxes= exons; blue boxes= 3′ 
and 5′ untranslated regions.
Shimizu et al. Page 11
J Hum Genet. Author manuscript; available in PMC 2011 June 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Shimizu et al. Page 12
Table 1
Characteristics of subjects with Kawasaki disease.
US-UK KD (n=482) Japanese KD (n=200)
CAA−
(n=371)
CAA+
(n=111)
CAA−
(n=142)
CAA+
(n=58)
Male 235 (63%) 77 (69%) 75 (53%) 40 (69%)
Self reported ethnicity
Caucasian 215 (58%) 75 (68%)
Caucasian-Hispanic 56 (15%) 12 (11%)
Asian, unspecified 42 (11%) 13 (12%)
Mixed 43 (12%) 8 (7%)
Others 14 (4%) 3 (2%)
Japanese 1 (0.2%) 0 (0%) 142 (100%) 58 (100%)
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